Synovus Financial’s Accelerate Diagnostics AXDX Stock Holding History

Synovus Financial’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-140	Closed	-$21K	–	751
2020 Q2	$21K	Hold	140	–	–	﹤0.01%	1094
2020 Q1	$12K	Hold	140	–	–	﹤0.01%	1507
2019 Q4	$24K	Hold	140	–	–	﹤0.01%	1083
2019 Q3	$26K	Sell	140 -24	-15%	-$4.64K	﹤0.01%	1038
2019 Q2	$37K	Hold	164	–	–	﹤0.01%	888
2019 Q1	$34K	Hold	164	–	–	﹤0.01%	900
2018 Q4	$19K	Hold	164	–	–	﹤0.01%	991
2018 Q3	$38K	Hold	164	–	–	﹤0.01%	895
2018 Q2	$36K	Hold	164	–	–	﹤0.01%	841
2018 Q1	$37K	Buy	+164	New	+$43.1K	﹤0.01%	823
2017 Q2	–	Sell	-164	Closed	-$40K	–	801
2017 Q1	$40K	Hold	164	–	–	﹤0.01%	758
2016 Q4	$34K	Hold	164	–	–	﹤0.01%	773
2016 Q3	$45K	Hold	164	–	–	﹤0.01%	730
2016 Q2	$24K	Sell	164 -68	-29%	-$9.12K	﹤0.01%	752
2016 Q1	$33K	Sell	232 -39	-14%	-$5.5K	﹤0.01%	701
2015 Q4	$58K	Hold	271	–	–	﹤0.01%	645
2015 Q3	$44K	Hold	271	–	–	﹤0.01%	636
2015 Q2	$70K	Hold	271	–	–	﹤0.01%	560
2015 Q1	$61K	Hold	271	–	–	﹤0.01%	605
2014 Q4	$52K	Hold	271	–	–	﹤0.01%	629
2014 Q3	$58K	Hold	271	–	–	﹤0.01%	583
2014 Q2	$70K	Sell	271 -62	-19%	-$13.5K	﹤0.01%	536
2014 Q1	$73K	Hold	333	–	–	﹤0.01%	517
2013 Q4	$38K	Hold	333	–	–	﹤0.01%	588
2013 Q3	$45K	Buy	333 +20	+6%	+$1.78K	﹤0.01%	547
2013 Q2	$25K	Buy	+313	New	+$23.2K	﹤0.01%	608

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Synovus Financial's AXDX Position: Q3 2020 in Review

Synovus Financial sold out of Accelerate Diagnostics (AXDX) in Q3 2020, closing a stake of 140 shares — an estimated $21K sold.

Synovus Financial first reported a position in AXDX in Q2 2013 and held it in 26 quarters. The position peaked at $73K in Q1 2014. 112 funds tracked by Wall St. Rank hold AXDX as of Q3 2020.

Synovus Financial reported no remaining Accelerate Diagnostics position as of Q3 2020 after selling out during the quarter.
Synovus Financial sold 140 Accelerate Diagnostics shares in Q3 2020, an estimated $21K.
Synovus Financial first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 26 quarters.
Synovus Financial's Accelerate Diagnostics position peaked at $73K in Q1 2014.
112 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.